Georgia · 87624

Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types in Georgia

Georgia Medicare Avg
$34.42
0% above national avg
National Medicare Avg
$34.29
All states combined
Billed Charge (GA)
$134.46
What providers submit
Est. Commercial (GA)
$77.45
National avg: $76.81
Est. Cash / Self-Pay (GA)
$62.79
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.0K
Services in GA
9
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Georgia

Provider Medicare Services
Quest Diagnostics Clinical... $34.43 1.9K

Georgia Pricing in Context

In Georgia, CPT code 87624 (Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types) carries an average Medicare payment of $34.42 — 0% above the national benchmark of $34.29. 9 providers across the state submitted claims for this procedure in 2023, performing 2.0K total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Georgia is $134.46, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in Georgia lands near $77.45, with self-pay cash prices typically around $62.79. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types cost in Georgia?

The average Medicare payment for Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types in Georgia is $34.42, which is 0% above the national average of $34.29. Providers in GA typically bill $134.46 for this procedure.

What does Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types cost with insurance in Georgia?

With commercial insurance in Georgia, Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types costs an estimated $77.45. Without insurance, the estimated cash price is $62.79. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types in Georgia?

9 providers in Georgia billed Medicare for Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types in 2023, performing 2.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types cheaper in Georgia than the national average?

No — Detection Test By Nucleic Acid For Human Papillomavirus (hpv), High-Risk Types costs 0% above the national average in Georgia. The state average Medicare payment is $34.42 compared to $34.29 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial